Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spermidine for Prevention of Radiation-Induced Xerostomia
NCT07035626Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of spermidine in radiation-induced xerostomia (2 cohorts), sponsored by West China Hospital of Sichuan University. Primary endpoint: Radiation-induced xerostomia assessed by Xerostomia Questionnaire. Started Jun 2025; status: recruiting.
02
Drugs
spermidine
03
Conditions
radiation-induced xerostomia
Beyond the preview
Go deeper on NCT07035626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07035626.